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Background: Insulin sensitivity can be estimated using glucose disposal rate (M) measured during a hyperinsulinemic
euglycemic clamp (HEC) or insulin sensitivity index (SI) derived from a frequently sampled intravenous glucose
tolerance test (FSIVGTT). The commonly used homeostatic model assessment of insulin resistance (HOMA-IR)
which utilizes fasting glucose and insulin has been validated against M across several populations (r = 0.5-0.8).
This study sought to validate HOMA-IR against SI and M in an Afro-Caribbean population.
Findings: Sixty participants completed a 180-minute FSIVGTT and another 50 completed a 150-minute hyperinsulinemic
euglycemic clamp. In both groups, HOMA-IR was calculated and anthropometry and body composition using
dual energy x-ray absorptiometry (DEXA) were measured.
FSIVGTT: The participants were 55% male, age 23.1 ± 0.05 years, BMI 24.8 ± 6.3 kg/m2 and % body fat 25.0 ± 15.2
(mean ± SD). HEC: The participants were 44% male, age 27.3 ± 8.1 years, BMI 23.6 ± 5.0 kg/m2 and % body fat
24.7 ± 14.2 (mean ± SD). While HOMA-IR, SI and M correlated with waist, BMI and % body fat (P-values < 0.01)
there were no significant correlations between HOMA-IR with either SI or M-value (P-values > 0.2).
Conclusions: In young Afro-Caribbean adults, HOMA-IR compared poorly with other measures of insulin sensitivity.
It remains important to determine whether similar findings occur in a more insulin resistant population. However,
HOMA-IR correlated with clinical measures of insulin sensitivity (i.e. adiposity), so it may still be useful in epidemiological
studies.
Keywords: Insulin sensitivity, Whole body glucose disposal, Insulin sensitivity index, Homeostatic model assessment of
insulin resistanceFindings
Background
Reduced insulin sensitivity is a predictor of incident type
2 diabetes and atherosclerotic risk [1]. The hyperinsuli-
nemic euglycemic clamp (HEC) is considered the gold
standard in vivo measurement of insulin sensitivity by
calculating whole body glucose disposal (M). As the
clamp is carried out under hyperinsulinemic conditions,
hepatic glucose output is generally suppressed [2] and
thus M mostly represents peripheral insulin sensitivity.
The frequently sampled intravenous glucose tolerance
test (FSIVGTT) measures whole body insulin sensitivity
through the calculation of the insulin sensitivity index* Correspondence: debbie.thompson@uwimona.edu.jm
1Tropical Medicine Research Institute, The University of the West Indies,
Mona, Kingston 7, Jamaica
Full list of author information is available at the end of the article
© 2014 Thompson et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium(SI) [3]. As both these measures are complex, the homeo-
static model assessment of insulin resistance (HOMA-IR)
is one of the most frequently used methods of determining
insulin resistance in large population based studies, since
it is mathematically derived from single fasting glucose
and insulin measurements.
HOMA-IR has been used to assess longitudinal changes
in insulin resistance in persons with type 2 diabetes of
various ethnic groups in order to examine the natural
history of diabetes and to assess the effects of treatment
[4]. It can also be utilized in non-diabetic populations
as it allows 1) comparisons of insulin sensitivity among
persons with abnormal glucose tolerance and 2) the
longitudinal assessment of persons who later develop
abnormal glucose tolerance [4]. HOMA-IR has been
validated against the HEC in multiple studies across
several populations (r = 0.5-0.8) [5]. Other indices thattral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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insulin sensitivity check index, QUICKI) have questionable
superiority to HOMA [6,7].
Afro-Caribbean adults have high rates of type 2 diabetes
and the metabolic syndrome, but there has been no
validation of these simple measures of insulin resistance in
this population. Consequently, we compared a simple sur-
rogate measure of insulin resistance/sensitivity, HOMA-IR
to measures derived from HEC and FSIVGTT in 110
non-diabetic Afro-Caribbean adults.
Methods
Study design
These data were derived from two observational studies
that utilized either a clamp or a FSIVGTT in 110 non-
diabetic Jamaican adults. Diabetes was excluded on the
basis of the patient’s stated history, a normal fasting
plasma glucose, as well as an oral glucose tolerance test.
In both studies, we excluded persons who were pregnant,
had renal impairment, used glucocorticoids or smoked.
None of the participants were taking drugs that affect in-
sulin action, viz. insulin sensitizers, hypolipidemic agents,
oral contraceptives or anabolic steroids. We also measured
anthropometry using a standardized protocol [8] and body
fat using dual energy x-ray absorptiometry.
The Faculty of Medical Sciences/University Hospital of
the West Indies Ethics Committee approved the protocols
and all participants gave written informed consent.
Data collection
In the first study [9], we recruited 60 participants age
22–23 years old from the Jamaican Birth Cohort. A
modified FSIVGTT was performed in the morning after
a 10 hour fast. After securing intravenous access in the
right antecubital vein, a 0.3 g/kg bolus of 50% dextrose
was given over 1 minute at time zero. At 20 minutes,
0.03 IU insulin per kg body weight was injected into the
right antecubital vein. Blood was collected at −10, −5, 0,
2, 3, 4, 5, 6, 8, 10 12, 14, 19, 22, 25, 30, 40, 50, 70, 100,
140 and 180 minutes to measure plasma glucose and
insulin concentrations. Glucose was measured using
glucose oxidase assay and plasma insulin measured
with an enzyme-linked assay (Immulite®, DPC, LA,
CA). The assay had an analytical sensitivity of 2 μIU/ml
and the intra-assay coefficient of variation (CV) was < 8%.
The MINMOD Millennium 6.02 software (MINMOD
Inc., Pasadena, CA, USA) was used to calculate SI.
We performed 150-minute hyperinsulinemic euglycemic
clamps in another study of 50 non-diabetic adults [10].
This included 40 survivors of childhood malnutrition and
10 age, sex and BMI-matched community controls who
were never exposed to malnutrition. The studies were
conducted in the morning after a 10 hour overnight
fast. We inserted a retrograde intravenous cannula intoa right dorsal metacarpal vein, and then the right hand
was placed in a warm box maintained at 50°C to
arterialize venous blood for intermittent sampling. In-
sulin was infused into a left antecubital vein at a rate of
1 mIU/kg/min and blood glucose was clamped at
5 mmol/l by means of a variable rate infusion of 20%
dextrose water. During the procedure, plasma glucose
concentrations were measured every 5 minutes from
the right cannula with a glucose analyzer (YSI Instruments,
Yellow Springs, OH). Additionally, blood was collected
every 10 minutes in a fluoridinated tube to measure
glucose and a heparinised tube to measure insulin levels.
Glucose was measured in the laboratory using glucose
oxidase and plasma insulin measured using an immuno-
assay technique (ALPCO, Salem, NH). The intra-assay
coefficient of variation was 3.13%.
The whole-body glucose disposal rate (M) was calculated
as the mean of the glucose infusion rate during steady state
of the clamp as follows:
M =GIR − SC; where GIR was the glucose infusion
rate and SC the space correction.
SC (mg/kg/min) = (G2-G1) × 0.63.
The steady state was defined as a 30 minute period oc-
curring after 120 minutes, during which the coefficients
of variation for blood glucose and GIR were less than
5% [11].
For all 110 participants, HOMA-IR was calculated as
follows [12]:
HOMA−IR ¼ fasting insulin uIU=mlð Þ  Fasting glucose
mmol
L
 
22:5
In our laboratory, the correlation between the insulin
assays used in both studies was 0.9.
Statistics
Continuous variables are presented as means ± SDs and in
highly skewed data we used medians with interquartile
ranges. HOMA-IR, SI and M were log transformed to a
normal distribution before the use of parametric tests.
Comparisons of means were assessed using 2 sample t-
test. Partial correlation coefficients were used to explore
the associations between HOMA-IR with M and SI,
controlling for age and sex. Statistical analyses were per-
formed using SPSS 16.0 (SPSS, Chicago, IL). P-values ≤
0.05 were considered statistically significant.
Results
The clinical characteristics of our study populations are
shown in the Table 1. The two groups did not differ with
respect to age or adiposity but the HEC group was more
insulin resistant using HOMA-IR (p < 0.0001).
Table 1 Clinical and metabolic characteristics of Afro-Caribbean adults who had FSIVGTT or HEC
Characteristics FSIVGTT HEC
Male (n = 33) Female (n = 27) Male (n = 22) Female (n = 28)
Age (years) 23.1 ± 0.5 23.1 ± 0.5 27.6 ± 9.1 27.0 ± 7.4
Height (cm) 177.0 ± 5.5 164.8 ± 7.2 171.7 ± 7.8 158.7 ± 7.1
Weight (kg) 73.4 ± 12.0 72.9 ± 25.3 69.0 ± 12.6 60.3 ± 16.2
BMI (kg/m2) 23.4 ± 3.4 26.6 ± 8.4 22.3 ± 3.8 23.8 ± 5.8
Waist (cm) 77.4 ± 8.1 81.4 ± 16.8 78.1 ± 9.9 75.7 ± 14.5
Percent body fat (%) 14.6 ± 8.8 37.7 ± 11.6 13.7 ± 8.7 33.3 ±11.4
Fasting glucose (mmol/l) l/L 5.1 ± 0.3 4.9 ± 0.4 4.1 ± 0.7 4.3 ± 0.5
Fasting insulin (uIU/ml) 2.0 (2.0, 2.0) 2.0 (2.0, 5.2) 10.4 (3.0, 17.6) 8.0 (4.5, 14.6)
M (mg.kg-1.min-1) - - 9.0 (5.9,12.1) 7.3 (5.2, 10.2)
SI [min
-1(μU/ml)] 2.2 (1.3, 3.4) 1.9 (0.6, 2.8) - -
HOMA-IR 0.44 (0.42, 0.52) 0.44 (0.40, 1.65) 1.6 (0.7, 3.0) 1.6 (0.9, 2.5)
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The participants were 55% male, age 23.1 ± 0.1 years and
BMI 24.8 ± 6.3 kg/m2. HOMA-IR did not correlate with
SI (Table 2, Figure 1) even after further adjustment for
BMI (r = 0.16, p = 0.25). However, HOMA-IR had signifi-
cant positive associations with weight, BMI, waist circum-
ference and % body fat. SI had negative associations with
weight, BMI, waist and % body fat (Table 2).
HEC
The participants were 44% male, age 27.3 ± 8.1 years and
BMI 23.6 ± 5.0 kg/m2. There was no significant correl-
ation between HOMA-IR and M (Table 2, Figure 2) even
after adjusting for BMI (r = −0.17, p = 0.26). Additionally,
no association between HOMA-IR and M was found in
a subgroup of 7 individuals that were diagnosed for the
first time with pre-diabetes during the study (r = −0.54;Table 2 Correlations (r) of clinical and metabolic characteristi
adults
Measurement FSIVGTT (55% male) N = 60
Correlations (r)
HOMA-IR
Age (years) −0.08
Height (cm) 0.23
Weight (kg) 0.39*
BMI (kg/m2) 0.36*
Waist (cm) 0.39*
Percent body fat (%) 0.29*
F glucose (mmol/l) l/L 0.45*
F insulin (uIU/ml) 0.99*
M (mg.kg-1.min-1) -
SI [min
-1(μU/ml)] −0.01
HOMA-IR 1.00*
Correlations are adjusted for age and sex; those that are statistically significant at thP = 0.22). M had significant negative associations with
weight, BMI, waist and % body fat (P-values ≤ 0.04).
Discussion
Fasting indices of insulin sensitivity compare poorly with
estimates derived from HEC and FSIVGTT in our study
population. While our findings contrast with data from
other populations, they were consistent with the findings
from studies in elderly diabetic Japanese and Greek
women with polycystic ovary syndrome [13]. Pisprasert
et al. concluded more recently that insulin sensitivity
indices based on fasting glucose and insulin levels
should be used cautiously as measures of peripheral in-
sulin sensitivity when comparing mixed gender and
mixed race populations [14]. Although our sample size
was comparatively small, other studies that validatedcs with measures of insulin sensitivity in Afro-Caribbean
HEC (44% male) N = 50
Correlations (r)
SI HOMA-IR M
0.05 −0.14 −0.18
0.03 −0.11 −0.02
−0.34* 0.01 −0.32*
−0.38* 0.08 −0.33*
−0.39* 0.06 −0.50*
−0.40* 0.10 −0.49*
0.08 0.07 −0.16
−0.02 0.99* −0.16
- −0.18 1.00*
1.00* - -
−0.01 1.00* −0.18
e 5% level are shown with an asterisk.
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Figure 1 Correlations between HOMA-IR and SI in non-diabetic
Afro-Caribbean adults (r = −0.14, P = 0.19).
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participants which is similar in size to our study [12].
There may be several factors that explain this apparent
inconsistency. First, African-Americans secrete more insu-
lin at any given level of insulin sensitivity [15] and their
rates of insulin clearance may be lower than Caucasians
[16]. Therefore in this population, fasting indices may
overestimate insulin resistance. This would also produce
stronger correlations in populations that are more insulin
resistant and/or diabetic as opposed to our participants
who were more insulin sensitive. While early beta cell
failure could also alter fasting indices, this is unlikely to
be the factor as African Americans have greater beta
cell function compared to Caucasians [17].
Additionally, insulin resistance is a heterogeneous en-
tity, that is, it impairs glucose uptake in several tissues
especially muscle and adipose tissues, as well as it affects
hepatic glucose output. Individuals may have varying
phenotypes of insulin resistance and, therefore, the calcu-0 10 20 30
0
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3
4
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6
7
8
M (mg/kg/min)
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M
A-
IR
Figure 2 Correlations between HOMA-IR and M in non-diabetic
Afro-Caribbean adults (r = −0.01, P = 0.93).lated indices may not completely reflect the in vivo milieu
[13]. Consequently, one possible explanation for the
lack of association in our population is a difference in
impaired peripheral insulin action compared to hepatic
insulin action. HOMA-IR and QUICKI are based on the
feedback loop of glucose and insulin in the post-absorptive
state and thus are more representative of hepatic insulin
resistance and hepatic glucose output. Interestingly, in
pre-pubertal and early pubertal adolescents, HOMA and
fasting insulin were shown to reflect total body insulin
sensitivity and hepatic insulin resistance, but not periph-
eral insulin sensitivity [18]. This is contrary to hyperinsuli-
nemic clamps performed at steady-state serum insulin
levels that suppress hepatic glucose production and
directly reflect glucose disposal predominantly into
skeletal muscle. On the other hand, the FSIVGTT com-
bines the effects of insulin to promote glucose disposal in
skeletal muscle and suppress hepatic glucose production
[19]. As a result, fasting indices may correlate poorly with
SI and M in persons who mostly have peripheral insulin
resistance. Afro-Americans have significant hepatic insulin
resistance compared to peripheral insulin sensitivity [20].
This is so despite African Americans having less hepatic
fat compared with Hispanics and Caucasians [20]. Whole
body insulin resistance may therefore equate to a different,
but overlapping set of metabolic derangements and may
reflect tissue-specific differences in insulin signaling [20].
Another factor that may have influenced our findings is
our relatively lean population. Fasting indices have been
shown to be less accurate in subjects with normal or near
normal weight [21]. The degree of obesity modifies the
relationships among insulin resistance, insulin secretion
and insulin catabolism such that plasma glucose and
insulin concentrations are better able to delineate dif-
ferences in more obese individuals [21]. Of note, however,
was the observation that HOMA-IR did correlate with
clinical measures of insulin resistance (i.e. adiposity) simi-
lar to SI and M.
Conclusion
In this first study exclusively investigating young, Afro-
Caribbean adults, we showed that fasting indices are not
equivalent to indices derived from the FSIVGTT or
HEC. Our findings, however, may have been influenced
by the fact that this population was lean and relatively
insulin sensitive. Fasting indices may therefore be less
reliable at predicting insulin sensitivity in this group,
and, by extension, in studies involving multiple ethnic
groups. In spite of this, fasting indices may still prove to
be useful as a ranking tool in epidemiological studies in
this population.
Abbreviations
HEC: Hyperinsulinemic euglycemic clamp; SI: Insulin sensitivity index;
FSIVGTT: Frequently sampled intravenous glucose tolerance test;
Thompson et al. BMC Research Notes 2014, 7:98 Page 5 of 5
http://www.biomedcentral.com/1756-0500/7/98HOMA-IR: Homeostatic model assessment of insulin resistance; M: Glucose
disposal rate; DEXA: Dual energy x-ray absorptiometry; QUICKI: Quantitative
insulin sensitivity check index.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DT collected the data and wrote the first draft of the manuscript. MSB
contributed to the study design, data collection and interpretation of the
data and reviewed the manuscript. CO contributed to the data analysis and
the writing of the manuscript. TSF, MKTR and RJW contributed to the
interpretation of the data, writing and review of the manuscript. AB contributed
to data collection and the writing of the manuscript. TEF contributed to the
study design, data collection, interpretation of the data, and writing of the
manuscript. All authors read and approved the final manuscript.
Acknowledgments
This work was partially supported by the National Institutes of Health
(5RO1 DK06689-08-12), the Health Research Council of New Zealand, and the
National Research Centre for Growth and Development (New Zealand).
Author details
1Tropical Medicine Research Institute, The University of the West Indies,
Mona, Kingston 7, Jamaica. 2MRC Lifecourse Epidemiology Unit,
Southampton General Hospital, Southampton, UK. 3Department of Surgery,
Radiology, Anesthesia and Intensive Care, The University of the West Indies,
Mona, Kingston 7, Jamaica.
Received: 11 March 2013 Accepted: 4 February 2014
Published: 20 February 2014
References
1. Hsueh WA, Law RE: Cardiovascular risk continuum: implications of insulin
resistance and diabetes. Am J Med 1998, 105(1A):4S–14S.
2. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose
production during hyperinsulinemic-euglycemic glucose clamps.
Comparison of unlabeled and labeled exogenous glucose infusates.
Diabetes 1987, 36(8):914–924.
3. McDonald C, Dunaif A, Finegood DT: Minimal-model estimates of insulin
sensitivity are insensitive to errors in glucose effectiveness. J Clin
Endocrinol Metab 2000, 85(7):2504–2508.
4. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling.
Diabetes Care 2004, 27(6):1487–1495.
5. Pacini G, Mari A: Methods for clinical assessment of insulin sensitivity and
beta-cell function. Best Pract Res Clin Endocrinol Metab 2003, 17(3):305–322.
6. Duncan GE, Hutson AD, Stacpoole PW: QUICKI does not accurately reflect
changes in insulin sensitivity with exercise training. J Clin Endocrinol
Metab 2001, 86(9):4115–4119.
7. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Urakawa H, Morioka K,
Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi, Y:
QUICKI is useful for following improvements in insulin sensitivity after ther-
apy in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2002,
87:2906–2908.
8. Ataman SL, Cooper R, Rotimi C, McGee D, Osotimehin B, Kadiri S, Kingue S,
Muna W, Fraser H, Forrester T, Wilks R: Standardization of blood pressure
measurement in an international comparative study. J Clin Epidemiol
1996, 49:869–877.
9. Thompson DS, Ferguson TS, Samms-Vaughan M, Wilks RJ, Phillips DI,
Osmond C, Forrester TE, Boyne MS: The interrelationship between birth
size, cortisol, adiponectin, IGF-I and glucose metabolism in Afro-
Caribbean young adults. Endo Rev 2011, 32:P3–523).
10. Thompson DS, Boyne MS, Osmond C, Byrne CD, Barnett AT, Hanson MA,
Gluckman PD, Forrester TE: Comparing insulin sensitivity in adult survivors
of malnutrition. J Dev Orig Health Dis 2011, 2(Suppl. 1):S113.
11. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method
for quantifying insulin secretion and resistance. Am J Physiol 1979,
237(3):E214–E223.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC:
Homeostasis model assessment: insulin resistance and beta-cell functionfrom fasting plasma glucose and insulin concentrations in man.
Diabetologia 1985, 28(7):412–419.
13. Diamanti-Kandarakis E, Kouli C, Alexandraki K, Spina G: Failure of
mathematical indices to accurately assess insulin resistance in lean,
overweight, or obese women with polycystic ovary syndrome. J Clin
Endocrinol Metab 2004, 89(3):1273–1276.
14. Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT: Limitations
in the use of indices using glucose and insulin levels to predict insulin
sensitivity: impact of race and gender and superiority of the indices
derived from oral glucose tolerance test in African Americans. Diabetes
Care 2013 Apr, 36(4):845–853.
15. Gower BA, Fernandez JR, Beasley TM, Shriver MD, Goran MI: Using genetic
admixture to explain racial differences in insulin-related phenotypes.
Diabetes 2003, 52(4):1047–1051.
16. Osei K, Schuster DP, Owusu SK, Amoah AG: Race and ethnicity determine
serum insulin and C-peptide concentrations and hepatic insulin extraction
and insulin clearance: comparative studies of three populations of West
African ancestry and white Americans. Metabolism 1997, 46(1):53–58.
17. Harris MI, Cowie CC, Gu K, Francis ME, Flegal K, Eberhardt MS: Higher
fasting insulin but lower fasting C-peptide levels in African Americans in
the US population. Diabetes Metab Res Rev 2002, 18(2):149–155.
18. Hoffman RP, Vicini P, Cobelli C: Pubertal changes in HOMA and QUICKI:
relationship to hepatic and peripheral insulin sensitivity. Pediatr Diabetes
2004, 5(3):122–125.
19. Muniyappa R, Lee S, Chen H, Quon MJ: Current approaches for assessing
insulin sensitivity and resistance in vivo: advantages, limitations, and
appropriate usage. Am J Physiol Endocrinol Metab 2008, 294(1):E15–E26.
20. Guerrero R, Vega GL, Grundy SM, Browning JD: Ethnic differences in hepatic
steatosis: an insulin resistance paradox? Hepatology 2009, 49(3):791–801.
21. Kim SH, Abbasi F, Reaven GM: Impact of degree of obesity on surrogate
estimates of insulin resistance. Diabetes Care 2004, 27(8):1998–2002.
doi:10.1186/1756-0500-7-98
Cite this article as: Thompson et al.: Limitations of fasting indices in the
measurement of insulin sensitivity in Afro-Caribbean adults. BMC Research
Notes 2014 7:98.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
